Actively Recruiting

Phase 3
Age: 6Years - 11Years
All Genders
Healthy Volunteers
NCT07567040

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

Led by Ohio State University · Updated on 2026-05-08

664

Participants Needed

14

Research Sites

105 weeks

Total Duration

On this page

Sponsors

O

Ohio State University

Lead Sponsor

N

National Eye Institute (NEI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aims of this clinical trial will test whether or not the onset of nearsightedness is delayed in a group of children randomized to nightly drops in 0.05% atropine in both eyes, in comparison to children who receiving nightly placebo drops in both eyes. The primary outcome is the two-year cumulative incidence of nearsightedness. The second aim of this project will determine whether atropine is associated with slower eye growth in children receiving nightly drops of atropine versus placebo.

CONDITIONS

Official Title

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

Who Can Participate

Age: 6Years - 11Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged 6 to 11 years
  • Refractive error (cycloplegic autorefraction, spherical equivalent) within specified ranges by age (6 years: -0.74 to +0.75 D; 7-8 years: -0.74 to +0.50 D; 9-10 years: -0.74 to +0.25 D; 11 years: -0.74 to plano)
  • Neither eye has -0.75 D or more myopia (spherical component)
  • Anisometropia less than 1.50 D difference between eyes
  • Astigmatism less than 1.50 DC in both eyes
  • Completed run-in period with at least 90% adherence to artificial tears for 2 to 4 weeks
Not Eligible

You will not qualify if you...

  • Randomization visit not completed within 4 weeks of baseline eligibility visit
  • Presence of strabismus (intermittent or constant) by cover test
  • Known allergy to atropine
  • Systemic diseases affecting eye accommodation or convergence (e.g., multiple sclerosis, myasthenia gravis, Graves ophthalmopathy, diabetes, Parkinson's, Down syndrome)
  • Ocular diseases such as congenital glaucoma, retinal disease, nystagmus, amblyopia
  • History of ocular surgery (e.g., cataracts, strabismus surgery)
  • Previous myopia prevention or control treatments for more than one month
  • Pregnancy by self-report

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 14 locations

1

University of Alabama School of Optometry

Birmingham, Alabama, United States, 35233

Not Yet Recruiting

2

University of California, Berkeley, School of Optometry

Berkeley, California, United States, 94720

Not Yet Recruiting

3

Southern California College of Optometry at Marshall B. Ketchum University

Fullerton, California, United States, 92831

Not Yet Recruiting

4

Stanford University

Palo Alto, California, United States, 94303

Not Yet Recruiting

5

Illinois College of Optometry

Chicago, Illinois, United States, 60616

Not Yet Recruiting

6

Indiana University

Bloomington, Indiana, United States, 47405

Not Yet Recruiting

7

New England College of Optometry

Boston, Massachusetts, United States, 02115

Not Yet Recruiting

8

State University of New York College of Optometry

New York, New York, United States, 10036

Not Yet Recruiting

9

Case Western Reserve Department of Ophthalmology

Cleveland, Ohio, United States, 44106

Not Yet Recruiting

10

The Ohio State University College of Optometry

Columbus, Ohio, United States, 43210

Actively Recruiting

11

Pennsylvania College of Optometry at Drexel University

Elkins Park, Pennsylvania, United States, 19027

Not Yet Recruiting

12

Southern College of Optometry

Memphis, Tennessee, United States, 38104

Not Yet Recruiting

13

University of Houston College of Optometry

Houston, Texas, United States, 77004

Not Yet Recruiting

14

Rosenberg College of Optometry at the University of Incarnate Word

San Antonio, Texas, United States, 78229

Not Yet Recruiting

Loading map...

Research Team

L

Lisa A Jordan, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial | DecenTrialz